The minimum BMI for semaglutide (Wegovy) under FDA labeling is 30 without any additional conditions, or 27 with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or dyslipidemia
These compounds are rather intensively produced under supra-nutritional Se intake (Itoh and Suzuki, 1997
Some recent patients of mine have asked if they should be taking peptides, no less physicians in San Diego sending me emails about whats going on with peptides
If you currently take or have recently taken any of these drugs, talk with your doctor about different treatment options
When it is rapid, it may not have sufficient time
De cualquier manera, hace falta evidencia ms concluyente